Citius Pharmaceuticals Inc (CTXR)

Dec 24, 2025

CITIUS PHARMACEUTICALS Q4 2025 Earnings Preview: Recent $CTXR Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative

Dec 24, 2025

Dec 24, 2025

Dow Gains Over 100 Points; US Jobless Claims Decline - Benzinga

Dec 24, 2025

Dec 24, 2025

Stock Market Today: Dow Jones, Nasdaq Futures Slip On Christmas Eve Despite Strong Q3 GDP Report— UiPath, AST SpaceMobile, Ramaco In Focus (UPDATED) - Benzinga

Dec 24, 2025

Dec 24, 2025

Citius Pharmaceuticals (CTXR) Surges 22% After Hours — Here's Why - Benzinga

Dec 24, 2025

Dec 24, 2025

UiPath, Ramaco Resources And 3 Stocks To Watch Heading Into Wednesday - Benzinga

Dec 24, 2025

Dec 23, 2025

Citius Pharmaceuticals Inc. Full Year Loss Decreases - Nasdaq

Dec 23, 2025

Dec 23, 2025

Citius Pharmaceuticals (CTXR) Reports Wider Annual Loss - GuruFocus

Dec 23, 2025

Dec 23, 2025

Citius Pharma launches cancer immunotherapy LYMPHIR in the U.S. By Investing.com - Investing.com Nigeria

Dec 23, 2025

Dec 23, 2025

Citius Pharmaceuticals, Inc. reports fiscal year 2025 financial results and provides business update - marketscreener.com

Dec 23, 2025

Dec 23, 2025

Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results And Provides Business Update - TradingView — Track All Markets

Dec 23, 2025

Dec 23, 2025

Citius Oncology Transitions to Commercial Stage: Analyzing the 10-K Filing and the 2026 Outlook for LYMPHIR - FinancialContent

Dec 23, 2025

Dec 23, 2025

Citius Pharmaceuticals (CTXR) Reports Earnings Miss with Increas - GuruFocus

Dec 23, 2025

Dec 23, 2025

Citius Pharma launches cancer immunotherapy LYMPHIR in the U.S. - Investing.com

Dec 23, 2025

Dec 23, 2025

CTXR: LYMPHIR's U.S. launch marks a pivotal year, with strong capital raises and ongoing pipeline progress - TradingView — Track All Markets

Dec 23, 2025

Dec 23, 2025

Citius Oncology, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update - Fidelity

Dec 23, 2025

Dec 23, 2025

Citius Pharmaceuticals, Inc. SEC 10-K Report - TradingView — Track All Markets

Dec 23, 2025

Dec 23, 2025

Citius Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended September 30, 2025 - marketscreener.com

Dec 23, 2025

Dec 21, 2025

How interest rate cuts could boost Citius Pharmaceuticals Inc. stockShort Setup & Stock Portfolio Risk Management - Улправда

Dec 21, 2025

Dec 20, 2025

Why Citius Pharmaceuticals Inc. stock remains resilientPortfolio Performance Report & Technical Pattern Based Buy Signals - Улправда

Dec 20, 2025

Dec 20, 2025

Is Citius Pharmaceuticals Inc. (47N0) stock a safe buy pre earningsExit Point & Daily Oversold Bounce Ideas - Bölüm Sonu Canavarı

Dec 20, 2025

Dec 19, 2025

Can Citius Pharmaceuticals Inc. stock resist market sell offsWeekly Stock Summary & Proven Capital Preservation Tips - Улправда

Dec 19, 2025

Dec 19, 2025

Sell Signal: How Citius Pharmaceuticals Inc. stock trades before earnings2025 Biggest Moves & Daily Growth Stock Investment Tips - Улправда

Dec 19, 2025

Dec 19, 2025

What analyst consensus says on Citius Pharmaceuticals Inc. stockJuly 2025 Recap & Low Risk High Win Rate Picks - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Layoff Watch: Can Citius Pharmaceuticals Inc. stock attract ESG capital inflowsWeekly Profit Summary & Community Consensus Trade Signals - Улправда

Dec 19, 2025

Dec 19, 2025

Analyst Calls: Will Citius Pharmaceuticals Inc. stock maintain dividend yieldInsider Selling & Precise Trade Entry Recommendations - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Will Citius Pharmaceuticals Inc. (47N0) stock outperform energy sector in 2025July 2025 Big Picture & Free Weekly Chart Analysis and Trade Guides - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Will Citius Pharmaceuticals Inc. stock maintain dividend yieldTrade Ideas & Free Real-Time Volume Trigger Notifications - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Will Citius Pharmaceuticals Inc. stock see insider buyingJuly 2025 Chart Watch & Real-Time Buy Signal Alerts - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Citius Pharmaceuticals Earnings Notes - Trefis

Dec 19, 2025

Dec 19, 2025

Is Citius Pharmaceuticals Inc. stock positioned for digital transformationOil Prices & Real-Time Volume Surge Alerts - ulpravda.ru

Dec 19, 2025

Dec 19, 2025

Why Citius Pharmaceuticals Inc. stock remains a top recommendationJuly 2025 Reactions & Real-Time Chart Breakout Alerts - Улправда

Dec 19, 2025

Dec 18, 2025

Will Citius Pharmaceuticals Inc. (47N0) stock outperform Dow JonesJuly 2025 PreEarnings & Weekly Return Optimization Plans - Улправда

Dec 18, 2025

Dec 18, 2025

Can Citius Pharmaceuticals Inc. stock attract ESG capital inflowsWeekly Earnings Recap & Consistent Profit Focused Trading Strategies - Улправда

Dec 18, 2025

Dec 18, 2025

Quarterly Earnings: How interest rate cuts could boost Citius Pharmaceuticals Inc. stockAnalyst Upgrade & Accurate Entry/Exit Alerts - Улправда

Dec 18, 2025

Dec 11, 2025

Citius Oncology closes $18 million in offerings to support LYMPHIR launch - Investing.com Nigeria

Dec 11, 2025

Dec 10, 2025

Citius Oncology Announces Closing of $18 Million Concurrent Regi - GuruFocus

Dec 10, 2025

Dec 10, 2025

Citius Oncology closes $18 million in offerings to support LYMPHIR launch By Investing.com - Investing.com South Africa

Dec 10, 2025

Dec 10, 2025

Citius Oncology (Nasdaq: CTOR) raises $18M at-the-market to fund LYMPHIR - Stock Titan

Dec 10, 2025

Dec 10, 2025

Citius Oncology shares sink after announcing $18M fundraising deal - MSN

Dec 10, 2025

Dec 09, 2025

Citius Oncology Announces $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules - Finviz

Dec 09, 2025

Dec 07, 2025

Aug Selloffs: Is Citius Pharmaceuticals Inc stock positioned for digital transformationPortfolio Gains Summary & Free Real-Time Volume Trigger Notifications - moha.gov.vn

Dec 07, 2025

Dec 05, 2025

Is Citius Pharmaceuticals Inc. (47N0) stock good for wealth creationJuly 2025 Momentum & Safe Investment Capital Preservation Plans - Newser

Dec 05, 2025

Dec 04, 2025

How Citius Pharmaceuticals Inc. (47N0) stock reacts to fiscal policiesJuly 2025 Big Picture & Trade Opportunity Analysis - Newser

Dec 04, 2025

Dec 04, 2025

CTXR: Analyst Jason Kolbert Maintains 'Buy' Rating with $6 Price Target | CTXR Stock News - GuruFocus

Dec 04, 2025

Dec 04, 2025

Citius Oncology Expands LYMPHIR™ Distribution to Turkey and Middle East Countries Through Exclusive Agreement with Er-Kim - The Malaysian Reserve

Dec 04, 2025

Dec 04, 2025

Citius Oncology Expands LYMPHIR™ Distribution to Turkey and Midd - GuruFocus

Dec 04, 2025

Dec 04, 2025

Citius Oncology Expands LYMPHIR™ Distribution to Turkey and Middle East Countries Through Exclusive Agreement with Er-Kim – Company AnnouncementFT.com - Financial Times

Dec 04, 2025

Dec 04, 2025

Citius Oncology Expands LYMPHIR Distribution to Turkey and Middle East Countries Through Exclusive Agreement with Er-Kim - Finviz

Dec 04, 2025

Dec 04, 2025

How supply shortages influence Citius Pharmaceuticals Inc. (47N0) stockWeekly Market Outlook & AI Powered Trade Plan Recommendations - Newser

Dec 04, 2025

Dec 04, 2025

How Citius Pharmaceuticals Inc. (47N0) stock responds to bond market2025 Investor Takeaways & AI Enhanced Trading Signals - Newser

Dec 04, 2025

Dec 03, 2025

Cutaneous T-cell Lymphoma Market Expected to Experience Major Growth by 2032, According to DelveInsight | Innate Pharma, Galderma R&D, Kyowa Kirin, Citius Pharma, Soligenix, 4SC AG, oligenix, Ligand - Barchart.com

Dec 03, 2025

Dec 03, 2025

Citius Oncology launches Lymphir treatment for rare lymphoma - NJBIZ

Dec 03, 2025

Dec 03, 2025

How Citius Pharmaceuticals Inc. (47N0) stock reacts to new regulations2025 Analyst Calls & Momentum Based Trading Signals - Newser

Dec 03, 2025

Dec 03, 2025

Is Citius Pharmaceuticals Inc. (47N0) stock vulnerable to rate hikesDollar Strength & Capital Efficiency Focused Ideas - Newser

Dec 03, 2025

Dec 02, 2025

Citius Oncology enters distribution services agreement with Cardinal Health - MSN

Dec 02, 2025